S/x on Dr/gs Reference
← Back to the matrix
Clinical evidence

Gabapentinoids

α2δ calcium-channel ligand·Medication side-effects

Effect across the cycle

DesireInhibitory: Decreased libido reported.
ArousalInhibitory: Reduced arousal.
PerformanceInhibitory: Erectile dysfunction common in case series.
ClimaxInhibitory: Characteristic anorgasmia and ejaculatory failure.
ExperienceNeutral: No prominent subjective-quality signature.
MemoryNeutral: Not a primary memory effect.

Mechanism

Bind the α2δ subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release involved in orgasm. Characteristically cause anorgasmia and ejaculatory failure, plus decreased libido and erectile dysfunction, at doses as low as 50–300 mg/day and not clearly dose-related.

Pharmacokinetics
Effects reported early; reversible on discontinuation.
Reversibility
Reversible on stopping.

Sex differences & notes

One pregabalin case series reported dysfunction in ~41% (erectile dysfunction 51.6%, anorgasmia 32.3%, low libido 35.5%).

Key sources

  • Hamed, Clin Neuropharmacol 2018
  • Grant & Oh, Am J Psychiatry 2002